Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06749288 · ClinicalTrials.gov registry record · NA

Radicle Revive 24: A Study of Health and Wellness Products on Menopausal Health and Related Health Outcomes

A NA study of Depression and Anxiety, sponsored by Radicle Science.

Completed
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06749288 is a NA study of Depression and Anxiety that has completed, run by Radicle Science. The registered enrollment target is 500 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06749288, a NA study of Depression and Anxiety, has completed, sponsored by Radicle Science.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

A randomized, double-blind, placebo-controlled, direct-to-consumer trial assessing the impact of health and wellness products on hormonal health and associated health outcomes in women with menopausal health issues

Interventions

  • DIETARY_SUPPLEMENT Radicle Revive Placebo Control Form 4.1
  • DIETARY_SUPPLEMENT Radicle Revive Active Study Product 4.1 Usage

Study Locations (1)

California

  • Radicle Science, Inc - Del Mar

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-01-01
Est. Completion 2025-07-01
Phase NA

Sponsor

Radicle Science

55 total trials

What the Registry Record Tells You About NCT06749288

The ClinicalTrials.gov registry entry for NCT06749288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (36% lower). The listed sponsor is Radicle Science, which has 55 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Radicle Revive Placebo Control Form 4.1 is the first listed.

NCT06749288 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06749288 about?

NCT06749288 is a clinical study titled "Radicle Revive 24: A Study of Health and Wellness Products on Menopausal Health and Related Health Outcomes". A randomized, double-blind, placebo-controlled, direct-to-consumer trial assessing the impact of health and wellness products on hormonal health and associated health outcomes in women with menopausal health issues

What is the current status of trial NCT06749288?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2025-01-01. Estimated completion is 2025-07-01.

What conditions does trial NCT06749288 study?

This clinical trial studies the following conditions: Depression, Anxiety, Fatigue, Sleep Disturbance, Menopause.

What interventions are being tested in trial NCT06749288?

The interventions under investigation include: Radicle Revive Placebo Control Form 4.1 (DIETARY_SUPPLEMENT), Radicle Revive Active Study Product 4.1 Usage (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06749288?

This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06749288 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.